NCT07019129

Brief Summary

Excessive exercise, disordered attitudes toward eating, physical and psychological stress, and/or hormonal imbalances may result in cessation of menstruation (secondary amenorrhea). The accompanying lack of estrogen may impair muscle power and oxygen recovery after exercise by reducing nitric oxide levels. The purpose of this study is to determine whether ingestion of beetroot juice containing nitrate, an alternative source of nitric oxide, can help reverse these changes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Sep 2025Jul 2026

First Submitted

Initial submission to the registry

June 5, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 13, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

September 5, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

September 24, 2025

Status Verified

September 1, 2025

Enrollment Period

8 months

First QC Date

June 5, 2025

Last Update Submit

September 22, 2025

Conditions

Keywords

dietary nitratesecondary amenorrheamuscle function

Outcome Measures

Primary Outcomes (2)

  • Maximal knee extensor power

    Maximal power of the knee extensor (thigh) muscles as determined using isokinetic dynamometry

    Approximately 2-3 hours after beetroot ingestion

  • Muscle reoxygenation kinetics

    Recovery rate constant (k) of muscle oxygenation following exercise as determined using NIRS (near-infrared spectroscopy) combined with brief intermittent arterial occlusion

    Approximately 2-3 hours after beetroot juice ingestion

Secondary Outcomes (3)

  • Maximal knee extensor velocity

    Approximately 2-3 hours after beetroot juice ingestion

  • Deoxygenation rate

    Approximately 2-3 hours after beetroot juice ingestion

  • Reoxygenation rate

    Approximately 2-3 hours after beetroot juice ingestion

Other Outcomes (6)

  • Baseline plasma nitrate/nitrite concentration

    Before beetroot juice ingestion

  • Plasma nitrate/nitrite concentration at 1 hour

    1 hour after beetroot juice ingestion

  • Plasma nitrate/nitrite concentration at 2 hours

    2 hours after beetroot juice ingestion

  • +3 more other outcomes

Study Arms (2)

Placebo

PLACEBO COMPARATOR

Nitrate-free beetroot juice

Dietary Supplement: Placebo Beetroot Juice Without Nitrate

Nitrate

EXPERIMENTAL

Nitrate-rich beetroot juice

Dietary Supplement: Beetroot Juice - Active

Interventions

Beetroot Juice - ActiveDIETARY_SUPPLEMENT

Nitrate-rich beetroot juice

Nitrate

Nitrate-poor beetroot juice

Placebo

Eligibility Criteria

Age18 Years - 44 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women age 18-44 years old
  • Missed \>3 consecutive periods in the last 12 months if previously regularly menstruating (average cycle 21-35 d) OR
  • Missed \>6 consecutive periods in the last 12 month if previously irregularly menstruating (spontaneous menstruation, average cycle \<21 or \> 35 d)

You may not qualify if:

  • Unable to provide informed consent
  • Currently diagnosed with primary amenorrhea (no history of menstruation by age 15) or oligomenorrhea (menstrual cycle \>35 d or \<8 cycles per year)
  • Currently diagnosed with a chronic illness, including thyroid disease, hyperprolactinemia, Cushing syndrome, and/or poly-cystic ovarian syndrome (PCOS)
  • History or current clinical diagnosis of an eating disorder
  • Currently dieting
  • Weight instablility for the past 3 months
  • Previously undergone a revascularization procedure involving a vascular graft or stenting of the femoral or popliteal arteries
  • Currently at the time of screening, or in the past year, using hormonal contraceptives
  • Pregnancy
  • Epilepsy
  • Current antibiotic use
  • Current nicotine user
  • Stage II hypertension (resting blood pressure \>140/\>90)
  • Currently taking proton pump inhibitors, antacids, xanthine oxidase inhibitors, or on hormone replacement therapy
  • If participant's doctor has ever said that he/she has a heart condition and that he/she should only do physical activity recommended by a doctor
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University Indianapolis

Indianapolis, Indiana, 46202, United States

RECRUITING

MeSH Terms

Interventions

Nitrates

Intervention Hierarchy (Ancestors)

AnionsIonsElectrolytesInorganic ChemicalsNitric AcidNitrogen CompoundsOrganic Chemicals

Study Officials

  • Andrew R Coggan, PhD

    Indiana University Indianapolis

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Andrew R Coggan, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 5, 2025

First Posted

June 13, 2025

Study Start

September 5, 2025

Primary Completion

May 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

September 24, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

All non-PHI individual participant data will be shared upon reasonable request.

Time Frame
Data will be made available upon completion of the study and publication of the final results.

Locations